Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique.
Renal radiofrequency (RF) ablation therapy is a safe and effective therapy for small renal cell carcinoma. Although the risk of complications is low, the potential for ureteral or calyceal injury does increase in the case of a centrally located lesion. A retrograde cold dextrose pyeloperfusion technique was designed to protect the collecting system in a patient who underwent percutaneous RF ablation of a central tumor of the left kidney.
Wah
Tze M
TM
Department of Radiology, St. James's University Hospital, Beckett Street, Leeds LS9 7TF, United Kingdom. tze.wah@leedsth.nhs.uk
Koenig
Philip
P
Irving
Henry C
HC
Gervais
Debra A
DA
Mueller
Peter R
PR
D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D003080:Cold Temperature; D005260:Female; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000601:surgery*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010477:Perfusion / Q000379:methods; D013549:Sweetening Agents / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D013549:Sweetening Agents; D005947:Glucose